Xenobiotics and human health: A new view of their pharma-nutritional role

PharmaNutrition

Volumn 3, Issue 2, 2015, Pages 60-64

  Visioli, Francesco ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Antioxidants; Hormesis; Nfr 2; Phase II enzymes; Polyphenols; Xenobiotics

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NUTRACEUTICAL; POLYPHENOL; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; CELL PROTECTION; DIMERIZATION; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; HUMAN; MOLECULAR WEIGHT; NUTRITIONAL HEALTH; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84927664254     PISSN: 22134344     EISSN: 22134344     Source Type: Journal    
DOI: 10.1016/j.phanu.2015.04.001     Document Type: Article

References (53)

1. Chiva-Blanch G., Visioli F. Polyphenols and health: moving beyond antioxidants. J. Berry Res. 2012, 2:63-71.
2. Forman H.J., Davies K.J., Ursini F. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 2014, 66:24-35. arxiv:/23747930, 10.1016/j.freeradbiomed.2013.05.045.
3. Gaman L., Stoian I., Atanasiu V. Can ageing be slowed?: hormetic and redox perspectives. J. Med. Life 2011, 4(4):346-351. arxiv:/22514565.
4. Calabrese E.J., Iavicoli I., Calabrese V. Hormesis: why it is important to biogerontologists. Biogerontology 2012, 13(3):215-235. arxiv:/22270337, 10.1007/s10522-012-9374-7.
5. Pilcher J.M., Young P., Weatherall M., Rahman I., Bonser R.S., Beasley R.W. A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery. J. R. Soc. Med. 2012, 105(10):436-445. arxiv:/23104947, 10.1258/jrsm.2012.120049.
6. Croom E. Metabolism of xenobiotics of human environments. Prog. Mol. Biol. Transl. Sci. 2012, 112:31-88. arxiv:/22974737, 10.1016/B978-0-12-415813-9.00003-9.
7. Vomhof-Dekrey E.E., Picklo M.J. The nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J. Nutr. Biochem. 2012, 23(10):1201-1206. arxiv:/22819548, 10.1016/j.jnutbio.2012.03.005.
8. Rebrin I., Sohal R.S. Pro-oxidant shift in glutathione redox state during aging. Adv. Drug Deliv. Rev. 2008, 60(13-14):1545-1552. arxiv:/18652861, 10.1016/j.addr.2008.06.001.
9. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 2009, 1790:1149-1160. arxiv:/19664690, 10.1016/j.bbagen.2009.07.026.
10. Van Remmen H., Jones D.P. Current thoughts on the role of mitochondria and free radicals in the biology of aging. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 2009, 64(2):171-174. arxiv:/19181714, 10.1093/gerona/gln058.
11. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247. arxiv:/11089981, 10.1038/35041687.
12. Hagen T.M., Moreau R., Suh J.H., Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-l-carnitine and/or lipoic acid. Ann. N. Y. Acad. Sci. 2002, 959:491-507. arxiv:/11976222.
13. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., Hagen T.M. Decline in transcriptional activity of nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(10):3381-3386. arxiv:/14985508, 10.1073/pnas.0400282101.
14. Suh J.H., Wang H., Liu R.M., Liu J., Hagen T.M. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 2004, 423(1):126-135. arxiv:/14871476, 10.1016/j.abb.2003.12.020.
15. Hall D.M., Sattler G.L., Sattler C.A., Zhang H.J., Oberley L.W., Pitot H.C., Kregel K.C. Aging lowers steady-state antioxidant enzyme and stress protein expression in primary hepatocytes. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 2001, 56(6):B259-B267. arxiv:/11382788, 10.1093/gerona/56.6.B259.
16. Huang C.S., Anderson M.E., Meister A. Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem. 1993, 268(27):20578-20583. arxiv:/8104188.
17. Huang C.S., Chang L.S., Anderson M.E., Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem. 1993, 268(26):19675-19680. arxiv:/8103521.
18. Lu S.C. Regulation of glutathione synthesis. Mol. Aspects Med. 2009, 30(1-2):42-59. arxiv:/18601945, 10.1016/j.mam.2008.05.005.
19. Stio M., Iantomasi T., Favilli F., Marraccini P., Lunghi B., Vincenzini M.T., Treves C. Glutathione metabolism in heart and liver of the aging rat. Biochem. Cell Biol. 1994, 72(1-2):58-61. arxiv:/7915119, 10.1139/o94-010.
20. Lee J.I., Kang J., Stipanuk M.H. Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation. Biochem. J. 2006, 393(1):181-190. arxiv:/16137247, 10.1042/BJ20051111.
21. Toroser D., Yarian C.S., Orr W.C., Sohal R.S. Mechanisms of gamma-glutamylcysteine ligase regulation. Biochim. Biophys. Acta 2006, 1760:233-244. arxiv:/16324789, 10.1016/j.bbagen.2005.10.010.
22. Zipper L.M., Mulcahy R.T. Inhibition of erk and p38 map kinases inhibits binding of nrf2 and induction of gcs genes. Biochem. Biophys. Res. Commun. 2000, 278(2):484-492. arxiv:/11097862, 10.1006/bbrc.2000.3830.
23. Song I.S., Tatebe S., Dai W., Kuo M.T. Delayed mechanism for induction of gamma-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling. J. Biol. Chem. 2005, 280(31):28230-28240. arxiv:/15946948, 10.1074/jbc.M413103200.
24. Yang H., Magilnick N., Ou X., Lu S.C. Tumour necrosis factor alpha induces co-ordinated activation of rat gsh synthetic enzymes via nuclear factor kappa B and activator protein-1. Biochem. J. 2005, 391(2):399-408. arxiv:/16011481, 10.1042/BJ20050795.
25. Shenvi S.V., Smith E.J., Hagen T.M. Transcriptional regulation of rat gamma-glutamate cysteine ligase catalytic subunit gene is mediated through a distal antioxidant response element. Pharmacol. Res. 2009, 60(4):229-236. arxiv:/19540342, 10.1016/j.phrs.2009.06.003.
26. Visioli F. Pharma and nutrition: crossing the Rubicon. PharmaNutrition 2013, 1(1).
27. Menendez J.A., Joven J., Aragones G., Barrajon-Catalan E., Beltran-Debon R., Borras-Linares I., Camps J., Corominas-Faja B., Cufi S., Fernandez-Arroyo S., Garcia-Heredia A., Hernandez-Aguilera A., Herranz-Lopez M., Jimenez-Sanchez C., Lopez-Bonet E., Lozano-Sanchez J., Luciano-Mateo F., Martin-Castillo B., Martin-Paredero V., Perez-Sanchez A., Oliveras-Ferraros C., Riera-Borrull M., Rodriguez-Gallego E., Quirantes-Pine R., Rull A., Tomas-Menor L., Vazquez-Martin A., Alonso-Villaverde C., Micol V., Segura-Carretero A. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle 2013, 12(4):555-578. arxiv:/23370395, 10.4161/cc.23756.
28. Schaffer S., Asseburg H., Kuntz S., Muller W.E., Eckert G.P. Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria. Mol. Neurobiol. 2012, 46(1):161-178. arxiv:/22706880, 10.1007/s12035-012-8282-9.
29. Grande S., Bogani P., de Saizieu A., Schueler G., Galli C., Visioli F. Vasomodulating potential of Mediterranean wild plant extracts. J. Agric. Food Chem. 2004, 52(16):5021-5026. arxiv:/15291469, 10.1021/jf049436e.
30. Rossoni G., Grande S., Galli C., Visioli F. Wild artichoke prevents the age-associated loss of vasomotor function. J. Agric. Food Chem. 2005, 53(26):10291-10296. arxiv:/16366729, 10.1021/jf052499s.
31. Smith A.R., Visioli F., Frei B., Hagen T.M. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2a. Aging Cell 2006, 5(5):391-400. arxiv:/16930126, 10.1111/j.1474-9726.2006.00232.x.
32. Smith A.R., Visioli F., Frei B., Hagen T.M. Lipoic acid significantly restores, in rats, the age-related decline in vasomotion. Br. J. Pharmacol. 2008, 153(8):1615-1622. arxiv:/18297110, 10.1038/bjp.2008.28.
33. Smith A.R., Visioli F., Hagen T.M. Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age. Arch. Biochem. Biophys. 2006, 454(1):100-105. arxiv:/16982030, 10.1016/j.abb.2006.02.017.
34. Visioli F. Nutritional support in the pharmacological treatment of metabolic syndrome. Eur. J. Pharmacol. 2011, 668(Suppl. 1):S43-S49. arxiv:/21813086, 10.1016/j.ejphar.2011.05.083.
35. Visioli F. Olive oil phenolics: where do we stand? Where should we go?. J. Sci. Food Agric. 2012, 92(10):2017-2019. arxiv:/22549365, 10.1002/jsfa.5715.
36. Visioli F., De La Lastra C.A., Andres-Lacueva C., Aviram M., Calhau C., Cassano A., D'Archivio M., Faria A., Favé G., Fogliano V., Llorach R., Vitaglione P., Zoratti M., Edeas M. Polyphenols and human health: a prospectus. Crit. Rev. Food Sci. Nutr. 2011, 51(6):524-546. arxiv:/21929330, 10.1080/10408391003698677.
37. Lotito S.B., Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?. Free Radical Biol. Med. 2006, 41(12):1727-1746. arxiv:/17157175, 10.1016/j.freeradbiomed.2006.04.033.
38. Gutteridge J.M., Halliwell B. Antioxidants: molecules, medicines, and myths. Biochem. Biophys. Res. Commun. 2010, 393(4):561-564. arxiv:/20171167, 10.1016/j.bbrc.2010.02.071.
39. Halliwell B. Free radicals and antioxidants - quo vadis?. Trends Pharmacol. Sci. 2011, 32(3):125-130. arxiv:/21216018, 10.1016/j.tips.2010.12.002.
40. Visioli F. Polyphenol studies: time for a physiological tea party?. Br. J. Nutr. 2011, 106(9):1321-1322. arxiv:/21854686, 10.1017/S0007114511004326.
41. Del Rio D., Rodriguez-Mateos A., Spencer J.P., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013, 18:1818-1892. arxiv:/22794138, 10.1089/ars.2012.4581.
42. Pecorari M., Villaño D., Testa M.F., Schmid M., Serafini M. Biomarkers of antioxidant status following ingestion of green teas at different polyphenol concentrations and antioxidant capacity in human volunteers. Mol. Nutr. Food Res. 2010, 54(Suppl. 2):S278-S283. arxiv:/20521272, 10.1002/mnfr.200900583.
43. Bannister J.V., Bannister W.H., Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. C.R.C. Crit. Rev. Biochem. 1987, 22(2):111-180. arxiv:/3315461, 10.3109/10409238709083738.
44. Michels A.J., Hagen T.M., Frei B. A new twist on an old vitamin: human polymorphisms in the gene encoding the sodium-dependent vitamin C transporter 1. Am. J. Clin. Nutr. 2010, 92(2):271-272. arxiv:/20592130, 10.3945/ajcn.2010.29979.
45. Visioli F., Davalos A. Polyphenols and cardiovascular disease: a critical summary of the evidence. Mini Rev. Med. Chem. 2011, 11(14):1186-1190. arxiv:/22070684.
46. Georgiou N.A., Garssen J., Witkamp R.F. Pharma-nutrition interface: the gap is narrowing. Eur. J. Pharmacol. 2011, 651(1-3):1-8. arxiv:/21114994, 10.1016/j.ejphar.2010.11.007.
47. Visioli F., Wolfram R., Richard D., Abdullah M.I., Crea R. Olive phenolics increase glutathione levels in healthy volunteers. J. Agric. Food Chem. 2009, 57(5):1793-1796. arxiv:/19219997, 10.1021/jf8034429.
48. Crespo M.C., Tomé-Carneiro J., Burgos-Ramos E., Loria Kohen V., Espinosa M.I., Herranz J., Visioli F. One-week administration of hydroxytyrosol to humans does not activate phase ii enzymes. Pharmacol. Res. 2015, (in press). 10.1016/j.phrs.2015.03.018.
49. Kotronoulas A., Pizarro N., Serra A., Robledo P., Joglar J., Rubió L., Hernaéz A., Tormos C., Motilva M.J., Fitó M., Covas M.I., Solà R., Farré M., Saez G., de la Torre R. Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats. Pharmacol. Res. 2013, 77:47-56. arxiv:/24044986, 10.1016/j.phrs.2013.09.001.
50. Balstad T.R., Carlsen H., Myhrstad M.C., Kolberg M., Reiersen H., Gilen L., Ebihara K., Paur I., Blomhoff R. Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo - studies in electrophile response element transgenic mice. Mol. Nutr. Food Res. 2011, 55(2):185-197. arxiv:/20827676, 10.1002/mnfr.201000204.
51. Mahabir S. Methodological challenges conducting epidemiological research on nutraceuticals in health and disease. PharmaNutrition 2014, 2(3):120-125. 10.1016/j.phanu.2013.06.002.
52. Weenen T.C., Pronker E.S., Commandeur H.R., Claassen E. Patenting in the European medical nutrition industry: trends, opportunities and strategies. PharmaNutrition 2013, 1(1):13-21. 10.1016/j.phanu.2012.10.003.
53. Hagen T.M., Vinarsky V., Wehr C.M., Ames B.N. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid. Redox Signal. 2000, 2(3):473-483. arxiv:/11229361, 10.1089/15230860050192251.